The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 20 May 2017
At a glance
- Drugs Fenofibric-acid (Primary) ; Lopinavir/ritonavir (Primary) ; Ritonavir (Primary)
- Indications HIV infections; Hyperlipidaemia
- Focus Pharmacokinetics
- 21 Mar 2012 Lead trial investigator (Scott R Penzak) identified as reported by ClinicalTrials.gov.
- 08 Feb 2012 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 03 Feb 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.